Sodium Hydroxide → 2-Piperidin-2-ylmethylbenzothiazole

HRID 2077290Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2077290
[S:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[CH2:10][CH:11]1[CH2:16][CH2:15][CH2:14][CH2:13][N:12]1C(=O)C(F)(F)F.[OH-].[Na+]>CO>[NH:12]1[CH2:13][CH2:14][CH2:15][CH2:16][CH:11]1[CH2:10][C:2]1[S:1][C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=1

Komponenten

4

Edukt 2

HCID 14798Sodium HydroxideHCID 231464011-(2-Benzothiazol-2-ylmethylpiperidin-1-yl)-2,2,2-trifluoroethanone

Produkt 1

HCID 231463502-Piperidin-2-ylmethylbenzothiazole

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 887MethanolLösungsmittel

Versuchsvorschrift

1-(2-Benzothiazol-2-ylmethylpiperidin-1-yl)-2,2,2-trifluoroethanone, D29 (1.2 g) was dissolved in methanol (40 ml) and 2N sodium hydroxide solution (20 ml) and heated to 50° C. for 0.75 h. After cooling, the reaction solution was partitioned between dichloromethane and water. The organic solution was dried (MgSO4) and the solvent removed in vacuo. The residue was chromatographed (silica gel, 0-10% [9:1 MeOH/conc. ammonia solution] in dichloromethane) to afford the title compound (0.68 g).

Aufarbeitung

  1. temperatureAfter cooling
  2. customthe reaction solution was partitioned between dichloromethane and water
  3. dry with materialThe organic solution was dried (MgSO4)
  4. customthe solvent removed in vacuo
  5. customThe residue was chromatographed (silica gel, 0-10% [9:1 MeOH/conc. ammonia solution] in dichloromethane)

Quellen und Nachweise

ORD-Eintrag
ord-c87b01e8f2e44c818c04f26f8db9d4ae
Quelldatensatz
uspto-grants-2011_04
Patentnummer
US07928124B2

Notizen zur Reaktion

Wird geladen…